About the Iridocyclitis Session
Iridocyclitis, also referred to as anterior uveitis, involves inflammation of the iris and the ciliary body. It manifests with symptoms such as eye redness, pain, light sensitivity, and blurred vision. Causes include infections (bacterial, viral, fungal), autoimmune disorders like rheumatoid arthritis, eye trauma, or may be idiopathic. Diagnosis requires a thorough eye examination, often employing slit-lamp biomicroscopy to assess the anterior chamber.
Treatment focuses on reducing inflammation and alleviating symptoms. This typically involves topical corticosteroid eye drops to reduce inflammation, pupil dilators to prevent adhesions, and management of underlying conditions if identified. Vigilant monitoring is essential to prevent complications such as glaucoma or cataracts arising from prolonged inflammation.
Topics Covered in Iridocyclitis
HLA-B27 Anterior Uveitis
Anterior Chamber Cells & Flare
Keratic Precipitates
Posterior Synechiae
Topical Corticosteroids
Cycloplegic Agents
Related Scientific Sessions at IOC 2027
Why Attend the Iridocyclitis Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Iridocyclitis work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Iridocyclitis research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Iridocyclitis track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Iridocyclitis Conference 2027 — FAQs
What is the Iridocyclitis track at IOC 2027?
The Iridocyclitis track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Iridocyclitis. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Iridocyclitis sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Iridocyclitis are all welcome — whether presenting or attending.
Can I present my research in the Iridocyclitis track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Iridocyclitis sessions?
Yes. IOC 2027 is a hybrid conference — attend the Iridocyclitis track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.